Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLG | P00747 | 5/20 | 0.45 |
| ▸ | CTSS | P25774 | 6/20 | 0.45 |
| ▸ | CTSK | P43235 | 5/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11652135 | 0.87 | PTPN1 (0.54) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL9646827 | 0.87 | PTPN1 (0.54) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL7057456 | 0.87 | PTPN1 (0.54) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL29397682 | 0.87 | PTPN1 (0.54) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL29400153 | 0.87 | PTPN1 (0.54) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL29787421 | 0.87 | PLG (0.50) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL10941372 | 0.83 | PLG (0.56) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL10941364 | 0.83 | PLG (0.56) | PLGCTSSCTSKPTPN1HDAC8 | |
| SCHEMBL14933160 | 0.82 | SMN1; SMN2 (0.46) | CTSSCTSKHDAC8TACR1ABCB1 | |
| SCHEMBL16124354 | 0.82 | SMN1; SMN2 (0.46) | CTSSCTSKHDAC8TACR1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | IAPP, GLP1R, VIP | PLG 905/4885CTSS 1601/4885CTSK 1231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.